4.7 Review

Apprising Diagnostic and Prognostic Biomarkers in Cutaneous Melanoma-Persistent Updating

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View

Aigli Korfiati et al.

Summary: In this study, the diagnostic and prognostic value of miRNAs in cutaneous melanoma (CM) was investigated. Using advanced bioinformatics tools, the authors analyzed miRNA expression profiles and developed specific non-linear classification models to predict CM recurrence and metastasis. The results showed high accuracy in predicting CM outcomes, indicating the potential of miRNAs as diagnostic and prognostic biomarkers.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

GLI-1 polymorphisms of Hedgehog pathway as novel risk and prognostic biomarkers in melanoma patients

Marija Dunjic et al.

Summary: This study revealed an association between genetic polymorphisms in the GLI1 gene of the sonic hedgehog (SHH) signaling pathway and prognosis of melanoma skin cancer patients. It found that patients with a specific GLI1 variant genotype had poorer overall survival and recurrence-free survival. Additionally, carriers of mutated alleles in GLI1 were found to have an increased risk of melanoma. This suggests GLI1 could serve as a novel marker for melanoma prognosis and a potential drug target for anti-cancer treatment.

MELANOMA RESEARCH (2022)

Review Oncology

Eosinophils and melanoma: Implications for immunotherapy

India Robinson et al.

Summary: New therapies like immune checkpoint blockers (ICB) have improved survival for advanced melanoma patients, but they can also cause side effects. Recent studies suggest that eosinophil counts and serum levels of eosinophil cationic protein are associated with prolonged survival in advanced melanoma, indicating a potential role for eosinophils in modulating treatment response.

PIGMENT CELL & MELANOMA RESEARCH (2022)

Article Oncology

The Effects of Hedgehog Signaling Pathway on the Proliferation and Apoptosis of Melanoma Cells

Zhi-Peng Peng et al.

Summary: This study investigates the effect of the Hedgehog signaling pathway on the proliferation and apoptosis of human malignant melanoma cells. The results show that the Hedgehog signaling pathway inhibitor cyclopamine can inhibit the proliferation and viability of melanoma cells, as well as induce cell apoptosis. This suggests that the Hedgehog signaling pathway could be a potential target for the treatment of malignant melanoma.

JOURNAL OF ONCOLOGY (2022)

Review Cell Biology

Complex roles of nicotinamide N-methyltransferase in cancer progression

Weixuan Wang et al.

Summary: Nicotinamide N-methyltransferase (NNMT) plays critical roles in cancer progression by affecting cellular methylation reactions and signaling pathways, and it has been identified as a potential biomarker and therapeutic target for tumor diagnosis and treatment.

CELL DEATH & DISEASE (2022)

Article Oncology

Combination of preoperative red cell distribution width and neutrophil to lymphocyte ratio as a prognostic marker for gastric cancer patients

Lei Fu et al.

Summary: The study demonstrated that the R-NLR score based on RDW and NLR is a promising predictor for the prognosis of stage II-III gastric cancer patients who have undergone radical gastrectomy. It can stratify patients preoperatively and guide clinical treatment decisions for better outcomes.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

Identifying FBLN1 (Gene ID: 2192) as a Potential Melanoma Biomarker for Melanoma based on an Analysis of microRNA Expression Profiles in the GEO and TCGA Databases

Xiao-Tian Liu et al.

Summary: This study identified 127 differentially expressed genes between normal melanocytes and melanoma cell lines, associated with extracellular junctions, migration, paracrine, and proliferation functions. The downregulation of the Fibulin 1 (FBLN1) gene was significantly linked to better overall survival in melanoma patients, suggesting its potential as a biomarker and prognostic factor for melanoma. Further analysis confirmed the low expression of FBLN1 in melanoma and its association with DNA copy number alterations in melanoma cell lines.

GENETIC TESTING AND MOLECULAR BIOMARKERS (2021)

Article Surgery

Melanoma Risk Factors and Prevention

William W. Dzwierzynski

CLINICS IN PLASTIC SURGERY (2021)

Review Biotechnology & Applied Microbiology

Role of Biomarkers in the Integrated Management of Melanoma

Piyu Parth Naik

Summary: Melanoma is an aggressive skin cancer and early detection is crucial. The high number of new cases reported in the US has led to increased focus on metastatic lesions and novel therapies.

DISEASE MARKERS (2021)

Article Biochemistry & Molecular Biology

The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells

Ignazia Tusa et al.

Summary: The study identified a novel Hedgehog-GLI-ERK5 axis that regulates melanoma cell growth, showing that activation of the Hedgehog-GLI pathway increased ERK5 expression and that inhibitors targeting both pathways were more effective in reducing melanoma cell viability and colony formation compared to single treatments.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Targeted Metabolomics Identifies Plasma Biomarkers in Mice with Metabolically Heterogeneous Melanoma Xenografts

Daniela D. Weber et al.

Summary: Metabolomic analysis revealed significant differences in the metabolism of melanoma subtypes, with potential biomarkers identified for melanoma screening. This highlights the metabolic heterogeneity of melanomas and suggests a diagnostic biomarker signature for potential screening of melanoma.

CANCERS (2021)

Article Medicine, Research & Experimental

Lymphocyte cytosolic protein 2 is a novel prognostic marker in lung adenocarcinoma

Yishan Huo et al.

Summary: The study found that LCP2 is a favorable prognostic biomarker in LUAD patients, with its expression correlated with clinical stage and lymph node metastasis. High LCP2 expression was associated with increased overall survival, potentially due to an enrichment of immune functions. Additionally, LCP2 expression was positively correlated with PD-L1 expression in LUAD tissues.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2021)

Review Dermatology

Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target

M. Perez et al.

Summary: The article discusses the role of glycans in melanoma progression, particularly focusing on the specialized function of GCNT2 in melanoma pathogenesis. The regulation mechanisms of GCNT2 may highlight its potential as a predictive marker and therapeutic target.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Article Oncology

A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio

Zekeriya Hannarici et al.

Summary: Inflammation is known to impact cancer formation and prognosis. RLR, as a potential prognostic marker, has been found to be associated with both PFS and OS in patients with cutaneous MM. This study suggests that RLR may serve as an independent prognostic factor for both PFS and OS in MM patients.

MELANOMA RESEARCH (2021)

Article Biochemistry & Molecular Biology

Altered Glycosylation of Human Alpha-1-Acid Glycoprotein as a Biomarker for Malignant Melanoma

David Virag et al.

Summary: A high-resolution HILIC-MS/MS method was developed for analyzing N-glycan anthranilic acid derivatives, revealing differential glycan patterns in patients with high-risk malignant melanoma. The method successfully categorized samples based on their glycosylation pattern and showed superior diagnostic potential for malignant melanoma compared to traditional serological markers.

MOLECULES (2021)

Article Immunology

Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis an Immunotherapy Outcome

Kexin Yan et al.

Summary: A prognostic risk assessment model was established for M2-related coexpressed genes in melanoma, with NOTCH3, DBN1, KDELC2, and STAB1 identified as essential genes promoting M2 macrophage infiltration. These genes are involved in antigen treatment and presentation, chemokine, cytokine, T cell receptor pathway, and IFN-gamma pathway. The model showed good prognostic ability and may provide candidate biomarkers for melanoma treatment and monitoring.

JOURNAL OF IMMUNOLOGY RESEARCH (2021)

Article Immunology

A novel risk score predicts prognosis in melanoma: The combination of three tumor-infiltrating immune cells and four immune-related genes

Pin Wu et al.

Summary: The combination of TIICs and IRGs in the ICGS model showed higher accuracy and predictive ability for melanoma prognosis, validated by independent datasets. T cell mediated immune response and inflammatory response are highly associated with melanoma.

CLINICAL IMMUNOLOGY (2021)

Review Genetics & Heredity

Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis

Jyoti Motwani et al.

Summary: Melanoma is a serious form of skin cancer accounting for 80% of skin cancer deaths. Recent studies suggest that phenotype switching, rather than genetic alterations, plays a key role in melanoma invasiveness. The review discusses mutational, transcriptional, and epigenomic alterations contributing to tumour heterogeneity in melanoma, as well as three proposed models for explaining tumour progression.

GENES (2021)

Review Biochemistry & Molecular Biology

Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape

Veronica Romano et al.

Summary: Cutaneous melanoma tissue is a network of cancer cells and tumor microenvironment characterized by high structural and cellular plasticity. The interactions between TME components and cancer cells lead to dramatic alterations in ECM remodelling, stromal cell phenotypes, and therapeutic responses. Melanoma-associated fibroblasts (MAFs) and normal fibroblasts within TME play crucial roles in influencing melanoma growth and outcomes through their cellular interactions and secretory profiles.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Oncology

Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N-Methyltransferase as a Biomarker in Skin Cancers

Roberto Campagna et al.

Summary: Skin cancers, including malignant melanoma and non-melanoma skin cancer, are the most common type of malignancy in white populations, with increasing incidence rates globally. Due to their aggressive behavior and often late diagnosis, they pose a significant challenge for healthcare systems. Identifying new biomarkers for diagnosis, prognosis, and targeted therapy is crucial. Nicotinamide N-methyltransferase (NNMT) is emerging as a key player in the progression of various malignancies, including skin cancers, making it a potential target for future research in diagnostic and therapeutic applications.

CANCERS (2021)

Review Cell Biology

The Intersection of Purine and Mitochondrial Metabolism in Cancer

Humberto De Vitto et al.

Summary: This review highlights the essential role of nucleotides in cell growth and survival, as well as the impact of purine and mitochondrial metabolism in cancer progression, particularly in ovarian cancer. It also addresses the importance of metabolic rewiring in cancer and the potential utilization of purine synthesis and mitochondrial inhibitors for cancer treatment in the evolving landscape.

CELLS (2021)

Review Biochemistry & Molecular Biology

miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma

Mai-Huong Thi Nguyen et al.

Summary: Immune checkpoint inhibitors show promise in cancer treatment, but resistance in melanoma patients hinders their effectiveness. Recent studies explore the role of miRNAs in immune response and tumor microenvironment, suggesting their potential as key players in immunotherapy.

BIOMOLECULES (2021)

Article Multidisciplinary Sciences

A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8+ T cells

Zijun Wang et al.

Summary: LCP2 expression is upregulated in metastatic skin cutaneous melanoma and associated with good overall survival. It is involved in multiple immune response pathways and positively correlated with molecules in TCR signaling and immune checkpoints in melanoma. High LCP2 expression is positively correlated with tumor-infiltrating CD8(+) T cells and acts as a prognostic biomarker for progression-free survival in patients receiving anti-PD1 immunotherapy.

SCIENTIFIC REPORTS (2021)

Article Oncology

The prognostic value of red cell distribution width (RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in radiotherapy for oropharyngeal cancer

Emilia Staniewska et al.

Summary: The study showed that RDW and NLR are significant predictors of overall survival in oropharyngeal cancer patients undergoing radiotherapy, with NLR being identified as an independent prognostic factor. However, the clinical value of NLR may be limited due to its relatively low sensitivity and specificity.

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2021)

Review Oncology

MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets

Soudeh Ghafouri-Fard et al.

Summary: Melanoma is the deadliest form of skin cancer, with diverse molecular changes occurring during its pathogenesis. miRNAs have been identified to play a role in melanoma biology by modulating gene expression, potentially serving as important targets for research, biomarker application, and therapeutic development.

FRONTIERS IN ONCOLOGY (2021)

Review Cell Biology

Deciphering Epitranscriptome: Modification of mRNA Bases Provides a New Perspective for Post-transcriptional Regulation of Gene Expression

Suresh Kumar et al.

Summary: Gene regulation depends on dynamic and reversibly modifiable biological and chemical information in the epigenome/epitranscriptome, especially in animal systems, with vital roles in developmental processes and stress responses, although some underlying mechanisms are not fully understood.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

Plasma circulating cell free messenger RNA as a potential biomarker of melanoma

Michael Itak Ita et al.

Summary: This study revealed significant differences in the plasma transcriptomic profile of different melanoma patient groups, suggesting that these differences could potentially be utilized to identify novel therapeutic targets or biomarkers relevant to melanoma.

ACTA ONCOLOGICA (2021)

Article Oncology

The plasma exosomal miR-1180-3p serves as a novel potential diagnostic marker for cutaneous melanoma

Yeye Guo et al.

Summary: This study revealed that decreased exosomal miR-1180-3p in plasma could serve as a promising diagnostic marker for melanoma in Asian patients. The expression level of miR-1180-3p was found to be negatively correlated with the proliferation, migration, and invasion of melanoma cells. Functional analysis identified ST3GAL4 as a potential target gene that was negatively regulated by miR-1180-3p, contributing to the malignant phenotype of melanoma cells.

CANCER CELL INTERNATIONAL (2021)

Article Biochemistry & Molecular Biology

Profiling Cancer-Associated Fibroblasts in Melanoma

Federica Papaccio et al.

Summary: Research indicates that cancer-associated fibroblasts play significant roles in tumor growth, extracellular matrix remodeling, and inflammatory response. A thorough understanding of the melanoma-fibroblast relationship can expand treatment options.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Medicine, General & Internal

Identification of prognostic genes and construction of a novel gene signature in the skin melanoma based on the tumor microenvironment

Wang Yingjuan et al.

Summary: Skin melanoma, a highly prevalent and deadly cancer, exhibits varying mortality rates based on the local tumor microenvironment. A study analyzing gene expression in melanoma samples identified 10 genes related to survival outcomes, distinguishing patients into low- and high-risk groups with distinct immune statuses. These results provide insights into microenvironment-associated genes as potential therapeutic targets for melanoma patients.

MEDICINE (2021)

Article Oncology

Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines

Roberto Campagna et al.

Summary: Melanoma, despite its small proportion of all skin tumors, is a major contributor to skin cancer-related deaths. This study identified NNMT enzyme as a potential therapeutic target for melanoma treatment, demonstrating that reducing NNMT levels can significantly inhibit cell proliferation and migration, as well as enhance sensitivity to chemotherapy drugs in melanoma cells.

PIGMENT CELL & MELANOMA RESEARCH (2021)

Review Cell Biology

The Role of Glycosylation in Melanoma Progression

Chiara De Vellis et al.

Summary: Malignant melanoma, originating from the malignant transformation of melanocytes, is the most aggressive form of skin cancer. Aberrant glycosylation, including sialylation, fucosylation, and N- and I-glycan branching, is considered a hallmark of cancer and plays a role in promoting melanoma progression through activation of invasion and metastasis, immune evasion, and cell proliferation.

CELLS (2021)

Review Cell Biology

Molecular Markers and Targets in Melanoma

Cristina Teixido et al.

Summary: Melanoma develops as a result of genetic alterations and has seen significant advancements in treatment with targeted therapy and immune checkpoint inhibitors.

CELLS (2021)

Review Oncology

Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies

Cristian Scatena et al.

Summary: Recent genomic revolution has shed light on the genetic alterations of cutaneous melanoma, offering new insights and tools for personalized medicine. High-throughput genomic technologies have facilitated the profiling of melanoma, allowing better prediction of biological and clinical behaviors.

FRONTIERS IN ONCOLOGY (2021)

Article Genetics & Heredity

RTP4 is a novel prognosis-related hub gene in cutaneous melanoma

Yiqi Li et al.

Summary: Through gene network analysis and research, RTP4 was identified as a hub gene related to the prognosis of melanoma, and it was found that RTP4 is associated with immune cell infiltration as well as components of immune checkpoints.

HEREDITAS (2021)

Article Medicine, Research & Experimental

Targeting and pharmacology of an anti-IL13Rα2 antibody and antibody-drug conjugate in a melanoma xenograft model

Parul Gupta et al.

Summary: IL13R alpha 2 is a cell surface tumor antigen that shows overexpression in various tumor types. Studies on anti-IL13R alpha 2 antibody and antibody-drug conjugate have demonstrated favorable biodistribution, targeting potential, and anti-tumor activity. Both FMT and PET imaging techniques have shown excellent therapeutic efficacy of anti-IL13R alpha 2-Ab/ADC in the A375 xenograft model.
Review Biochemistry & Molecular Biology

Mechanisms and inhibitors of nicotinamide N-methyltransferase

Iredia D. Iyamu et al.

Summary: Nicotinamide N-methyltransferase (NNMT) plays a crucial role in regulating methylation potential and nicotinamide degradation in various biological processes. Aberrant expression of NNMT is associated with multiple diseases, leading to a growing interest in evaluating NNMT as a potential therapeutic target and developing NNMT inhibitors. Recent research has focused on understanding NNMT mechanisms, inhibitors, and future directions for drug development.

RSC MEDICINAL CHEMISTRY (2021)

Review Dermatology

Melanoma-associated glycosyltransferase GCNT(2) as an emerging biomarker and therapeutic target

M. Perez et al.

Summary: This review discusses the role of glycans in melanoma, specifically focusing on the specialized function of GCNT2 in melanoma pathogenesis. Aberrant expression of GCNT2 may serve as a predictive marker and potential therapeutic target in melanoma.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Article Biochemistry & Molecular Biology

Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma

Jiaheng Xie et al.

Summary: SLC16A1 is a robust prognostic biomarker for melanoma, associated with decreased overall survival in patients. It plays important roles in metabolic regulation, protein ubiquitination, and substance localization, and may serve as a novel target in immunotherapy.

CHANNELS (2021)

Article Oncology

The neutrophil-lymphocyte ratio and locoregional melanoma: a multicentre cohort study

Alyss V. Robinson et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)

Article Biochemistry & Molecular Biology

Role of fucosyltransferase IV in the migration and invasion of human melanoma cells

Xiu Shan et al.

IUBMB LIFE (2020)

Article Medicine, Research & Experimental

Identification of key genes involved in the pathogenesis of cutaneous melanoma using bioinformatics analysis

Jianqin Chen et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)

Letter Dermatology

Circulating miRNA expression analysis reveals new potential biomarkers for human cutaneous melanoma staging

B. Sanchez-Sendra et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Review Cell Biology

miRNAs in the Diagnosis and Prognosis of Skin Cancer

Monica Neagu et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Oncology

Tumor Cell-Derived Angiopoietin-2 Promotes Metastasis in Melanoma

Ashik Ahmed Abdul Pari et al.

CANCER RESEARCH (2020)

Article Biochemistry & Molecular Biology

Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis

Mariangela Kosmopoulou et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biotechnology & Applied Microbiology

Identification and Validation of Prognostically Relevant Gene Signature in Melanoma

Yali Gao et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Review Oncology

Metabolic Traits in Cutaneous Melanoma

Monica Neagu

FRONTIERS IN ONCOLOGY (2020)

Review Oncology

Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment

Angelica Avagliano et al.

FRONTIERS IN ONCOLOGY (2020)

Article Immunology

Antiganglioside Antibodies and Inflammatory Response in Cutaneous Melanoma

Corina Daniela Ene et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2020)

Letter Dermatology

BATF2 expression as a novel marker for invasive phenotype in malignant melanoma

Hidemi Tagawa et al.

JOURNAL OF DERMATOLOGY (2020)

Review Biochemistry & Molecular Biology

Lipids in the tumor microenvironment: From cancer progression to treatment

Kevin C. Corn et al.

PROGRESS IN LIPID RESEARCH (2020)

Article Biochemical Research Methods

Discovery of TBC1D7 as a Potential Driver for Melanoma Cell Invasion

Tianyu F. Qi et al.

PROTEOMICS (2020)

Article Oncology

Identification of prognostic mRNAs in metastatic cutaneous melanoma

Soohwan Lee et al.

MELANOMA RESEARCH (2020)

Article Immunology

Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma

Francesco Sabbatino et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Medicine, General & Internal

Recent Advances in Signaling Pathways Comprehension as Carcinogenesis Triggers in Basal Cell Carcinoma

Mircea Tampa et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

Overcoming Immune Evasion in Melanoma

Kevinn Eddy et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemical Research Methods

Novel MicroRNA Biomarkers, miR-142-5p, miR-550a, miR-1826, and miR-1201, Were Identified for Primary Melanoma

Yangchun Xu et al.

JOURNAL OF COMPUTATIONAL BIOLOGY (2020)

Article Biology

MicroRNA-107 is a novel tumor suppressor targeting POU3F2 in melanoma

Guizhi Zhao et al.

BIOLOGICAL RESEARCH (2020)

Article Dermatology

Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign

M. Suppa et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

Article Cell Biology

Platelet count correlates with stage and predicts survival in melanoma

Saleh Rachidi et al.

PLATELETS (2019)

Article Multidisciplinary Sciences

Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma

Hayato Okamoto et al.

SCIENTIFIC REPORTS (2019)

Article Medicine, General & Internal

Nicotinamide N-methyltransferase in nonmelanoma skin cancers

Veronica Pompei et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Dermatology

Prognostic implications of markers of the metabolic phenotype in human cutaneous melanoma

L. Najera et al.

BRITISH JOURNAL OF DERMATOLOGY (2019)

Article Oncology

Cancer statistics, 2019

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Review Oncology

Opposing roles of eosinophils in cancer

Sonja C. S. Simon et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)

Article Multidisciplinary Sciences

Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma

Emilia Hugdahl et al.

PLOS ONE (2019)

Review Oncology

Tumor infiltrating lymphocytes: The regulator of melanoma evolution

Mihaela Antohe et al.

ONCOLOGY LETTERS (2019)

Review Biochemical Research Methods

Recent advances in melanoma research via omics platforms

Carmen Rodriguez-Cerdeira et al.

JOURNAL OF PROTEOMICS (2018)

Review Oncology

Cutaneous melanoma: From pathogenesis to therapy (Review)

Giulia C. Leonardi et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2018)

Article Oncology

Serum exosomal microRNAs as potent circulating biomarkers for melanoma

Li Tengda et al.

MELANOMA RESEARCH (2018)

Article Biochemistry & Molecular Biology

Loss of miR-204 expression is a key event in melanoma

Marco Galasso et al.

MOLECULAR CANCER (2018)

Review Gastroenterology & Hepatology

Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis

Wei-Yu Xu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Article Multidisciplinary Sciences

Amino Acid Signature in Human Melanoma Cell Lines from Different Disease Stages

Christine Wasinger et al.

SCIENTIFIC REPORTS (2018)

Review Oncology

Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer

Taku Fujimura et al.

FRONTIERS IN ONCOLOGY (2018)

Article Endocrinology & Metabolism

Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma

A. W. L. Bayci et al.

METABOLOMICS (2018)

Article Multidisciplinary Sciences

Loss of GCNT2/I-branched glycans enhances melanoma growth and survival

Jenna Geddes Sweeney et al.

NATURE COMMUNICATIONS (2018)

Review Medicine, Research & Experimental

The role of the Hedgehog signaling pathway in cancer: A comprehensive review

Ana Marija Skoda et al.

BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2018)

Article Oncology

Basal neutrophil-to-lymphocyte ratio is associated with overall survival in melanoma

Leonardo S. Lino-Silva et al.

MELANOMA RESEARCH (2017)

Article Endocrinology & Metabolism

THE ROLE OF ESTROGENS AND ESTROGEN RECEPTORS IN MELANOMA DEVELOPMENT AND PROGRESSION

C. Caruntu et al.

ACTA ENDOCRINOLOGICA-BUCHAREST (2016)

Review Pathology

Angiogenesis in melanoma: an update with a focus on current targeted therapies

George Jour et al.

JOURNAL OF CLINICAL PATHOLOGY (2016)

Article Cell Biology

TNF Counterbalances the Emergence of M2 Tumor Macrophages

Franz Kratochvill et al.

CELL REPORTS (2015)

Article Cell Biology

Evolution of Tre-2/Bub2/Cdc16 (TBC) Rab GTPase-activating proteins

Carme Gabernet-Castello et al.

MOLECULAR BIOLOGY OF THE CELL (2013)

Review Oncology

Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?

Joannes F. M. Jacobs et al.

LANCET ONCOLOGY (2012)

Review Dentistry, Oral Surgery & Medicine

The role of eosinophils and eosinophil cationic protein in oral cancer: A review

Michele Conceicao Pereira et al.

ARCHIVES OF ORAL BIOLOGY (2011)

Article Biochemistry & Molecular Biology

The TRE17 oncogene encodes a component of a novel effector pathway for rho GTPases Cdc42 and Rac1 and stimulates actin remodeling

JM Masuda-Robens et al.

MOLECULAR AND CELLULAR BIOLOGY (2003)